An expert discusses how, for advanced unresectable hepatocellular carcinoma (uHCC), clinicians monitor treatment efficacy ...

Discover how Yttrium-90 radioembolisation may offer improved survival for large hepatocellular carcinoma tumours compared to ...

"Residual cancer is identified on histology in 40% of lung, 57–69% of renal cell, 7.7–47.6% of prostate and 0–86.7% of hepatocellular carcinoma." ...

The analysis included patients who were referred to the Department of Gastroenterology, Hepatology and Infectious Diseases, to the Department of Surgery or to the Department of Radiology and ...

Direct-acting antivirals (DAAs) have dramatically changed the landscape of chronic hepatitis C virus (HCV) treatment and ...

Hepatocellular carcinoma (HCC), the third leading cause of cancer-related deaths worldwide, remains one of the most ...

A research team led by Prof. Sun Cheng from the University of Science and Technology of China (USTC), in collaboration with ...

Hepatocellular carcinoma (HCC) represents a significant ... Recent advancements in liver imaging, particularly the use of hepatocyte-specific contrast agents, have enhanced the detection of ...

Radiotherapy, especially a form known as stereotactic ablative radiotherapy (SABR), is widely used to treat cancers in the ...

Table 3. Racial demographics of hepatocellular carcinoma cases (n = 48,596) in the USA, 2001–2006. Race Average annual number of cases Incidence rate over entire period Average annual % change ...